MBOT Microbot Medical Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$1.16
· of 52w range
· above low
· to high
$1.1452w low
$3.4652w high
Market Cap (MRQ)
$78M
P/E
-4.0
EPS
$-0.29
your badges
52W Range
$1–$3
Analyst Rating
BUY
Price Target
$6
P/E
-4.0
ROE
-24.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
MBOT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.16
Market Cap (MRQ)
$78M
P/E
-4.0
EPS
$-0.29
ROE
-24.4%
52W Range
$1–$3
MBOT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Sept. 5, 2018 | 1-for-15 | Reverse |
| Nov. 29, 2016 | 1-for-9 | Reverse |
| May 9, 2016 | 1-for-12 | Reverse |
| July 6, 2011 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.292022-12-31 → 2025-12-31
Free Cash Flow$-13M2016-12-31 → 2025-12-31
Net margin·2018-12-31 → 2018-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MBOT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -4.05Y avg ≈-2.9 | ≈-2.9 | · | · | |
| P/S | 681.95Y avg ≈441.7 | ≈441.7 | 12.2 | Overvalued | |
| P/B (MRQ) | 1.15Y avg ≈3.8 | ≈3.8 | 1.9 | Fair value | |
| Price / FCF (TTM) | -4.35Y avg ≈-4.5 | ≈-4.5 | · | · | |
| Price / Cash Flow (TTM) | -4.45Y avg ≈-4.6 | ≈-4.6 | · | · | |
| Price / Tangible Book | 1.05Y avg ≈3.8 | ≈3.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MBOT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -30.0%5Y avg ≈-92.5% | ≈-92.5% | -43.4% | Top tier | |
| ROE | -24.4%5Y avg ≈-158.6% | ≈-158.6% | -41.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MBOT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 18.65Y avg ≈8.0 | ≈8.0 | 3.8 | Strong liquidity | |
| Quick Ratio (MRQ) | 17.45Y avg ≈7.7 | ≈7.7 | 3.2 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
7.8%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $-0.08 | $-0.08 | -2.3% |
| March 31, 2026 | May 12, 2026 | $-0.05 | $-0.08 | 36.1% |
| Dec. 31, 2025 | $-0.04 | $-0.06 | 34.6% | |
| Sept. 30, 2025 | $-0.07 | $-0.06 | -14.4% | |
| June 30, 2025 | $-0.10 | $-0.08 | -22.5% | |
| March 31, 2025 | $-0.09 | $-0.13 | 32.1% | |
| Dec. 31, 2024 | $-0.20 | $-0.18 | -8.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | $116.9K | · | |
| R&D Expense | $6M | $7M | $6M | $8M | $6M | $3M | $3M | $3M | $1M | $-901.0K | $-823.0K | $22M | |
| SG&A Expense | $8M | $5M | $4M | $6M | $5M | $6M | $4M | $5M | $4M | $-9M | $-92.0K | $10M | |
| Operating Expenses | · | · | · | $5M | $4M | · | · | · | · | · | $37M | $32M | |
| Operating Income | $-15M | $-12M | $-10M | $-13M | $-11M | $-9M | $-7M | $-7M | $5M | $-10M | $915.0K | $-31M | |
| Interest Expense | · | · | · | · | · | · | · | · | $237.0K | $333.0K | $6.0K | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $7.5K | $8.5K | |
| Other Non-op | · | · | · | $-5.0K | · | · | · | · | · | · | $129.8K | $-45.8K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $36M | $33M | |
| Income Tax | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Net Income | $-13M | $-11M | $-11M | $-13M | $-11M | $-9M | $-7M | $-7M | $-8M | $-10M | $-921.0K | $-33M | |
| EPS (Basic) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | $-1.59 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 45,790,362 | 15,644,511 | 10,199,984 | 7,260,344 | 7,108,133 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 45,790,362 | 15,644,511 | 10,199,984 | 7,260,344 | · | · | · | · | · | · | · | · | |
| EBITDA | $-15M | $-12M | $-10M | $-13M | $-11M | · | · | $7M | $-5M | $10M | $-36M | $-30M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $2M | $2M | $13M | $20M | $29M | $5M | $11M | $3M | $437.0K | $791.0K | |
| Short-term Investments | $75M | $2M | $4M | $6M | $2M | $5M | $3M | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $159.5K | |
| Inventory | $584.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $644.0K | $300.0K | $152.0K | $532.0K | $300.0K | $521.0K | $286.0K | $568.0K | $81.0K | $191.0K | $25.0K | $1M | |
| Other Current Assets | · | · | $1M | · | $300.0K | $521.0K | $286.0K | $568.0K | $116.0K | $606.0K | · | $64.9K | |
| Current Assets | $80M | $6M | $8M | $9M | $16M | $25M | $36M | $6M | $11M | $3M | $491.0K | $27M | |
| PP&E (Net) | $93.0K | $80.0K | $146.0K | $221.0K | $244.0K | $251.0K | $228.0K | $259.0K | $90.0K | $53.0K | $38.0K | $5M | |
| PP&E (Gross) | $724.0K | $664.0K | $639.0K | $608.0K | $533.0K | $464.0K | $373.0K | $391.0K | $168.0K | $110.0K | $92.0K | $16M | |
| Accum. Depreciation | $631.0K | $584.0K | $493.0K | $387.0K | $289.0K | $213.0K | $145.0K | $132.0K | $78.0K | $57.0K | $54.0K | $10M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $45.8K | $356.9K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $742.7K | $373.7K | |
| Total Assets | $82M | $6M | $8M | $10M | $17M | $26M | $37M | $6M | $11M | $3M | $529.0K | $32M | |
| Accounts Payable | $511.0K | $165.0K | $357.0K | $116.0K | $279.0K | $275.0K | $284.0K | $630.0K | $78.0K | $512.0K | $25.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $1M | $2M | $1M | $883.0K | $795.0K | $755.0K | $450.0K | $271.0K | $149.0K | $5M | |
| Current Liabilities | $3M | $2M | $4M | $2M | $2M | $1M | $5M | $5M | $528.0K | $783.0K | $174.0K | $11M | |
| Capital Leases | $569.0K | $41.0K | $40.0K | $179.0K | $402.0K | $626.0K | $760.0K | · | · | · | $15.9K | $9.2K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $369.4K | $1M | |
| Total Liabilities | $4M | $3M | $4M | $2M | $2M | $2M | $6M | $5M | $556.0K | $1M | $419.0K | $27M | |
| Common Stock | $672.0K | $195.0K | $118.0K | $80.0K | $72.0K | $72.0K | $72.0K | $31.0K | $27.0K | $266.0K | $132.0K | $687.3K | |
| Paid-in Capital | · | · | · | · | · | · | · | $33M | $31M | $14M | $3M | · | |
| Retained Earnings | $-104M | $-91M | $-80M | $-69M | $-56M | $-44M | $-35M | $-28M | $-21M | $-13M | $-3M | $-420M | |
| Treasury Stock | · | · | · | · | · | · | $3M | $3M | · | · | · | · | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $47.4K | $65.4K | |
| Stockholders' Equity | $78M | $4M | $5M | $7M | $14M | $24M | $32M | $1M | $10M | $2M | $-64.0K | $857.0K | |
| Liabilities + Equity | $82M | $6M | $8M | $10M | $17M | $26M | $37M | $6M | $11M | $3M | $529.0K | $32M | |
| Shares Outstanding | 67,158,044 | 19,399,513 | 11,707,317 | 7,890,628 | 7,108,133 | 7,108,133 | 7,185,628 | 3,012,343 | 2,013,193 | 15,848,136 | 13,182,660 | 68,729,774 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $47.0K | $91.0K | $106.0K | $102.0K | $76.0K | $68.0K | $84.0K | $54.0K | · | · | $1M | $1M | |
| Stock-based Comp | $1M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $479.0K | $676.0K | · | $2M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $72.0K | $299.0K | |
| Other Non-cash | $-1M | $1M | $707.0K | $-235.0K | $497.0K | · | · | · | · | · | $365.5K | $2M | |
| Operating Cash Flow | $-13M | $-9M | $-9M | $-12M | $-9M | $-7M | $-6M | $-5M | $-5M | $-786.0K | $-765.0K | $-27M | |
| CapEx | $60.0K | $25.0K | $33.0K | $84.0K | $69.0K | $91.0K | $216.0K | $223.0K | $58.0K | $25.0K | $2.0K | $903.9K | |
| Investing Cash Flow | $-72M | $2M | $2M | $-4M | $3M | $-3M | $-2M | $-223.0K | $-58.0K | $-25.0K | $-2.0K | $-425.6K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Stock Issued | · | · | · | · | · | · | $37M | · | $13M | · | $26M | $19M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $13M | · | $26M | $19M | |
| Financing Cash Flow | $86M | $8M | $7M | $4M | · | $-3M | $37M | $-18.0K | $13M | $3M | $413.0K | $22M | |
| Net Change in Cash | $810.0K | $646.0K | $-2.0K | $-11M | $-6M | $-13M | $28M | $-6M | $8M | $2M | $-354.0K | $-6M | |
| Free Cash Flow | $-13M | $-9M | $-9M | $-12M | $-9M | · | · | $-6M | $-5M | $-811.0K | $-32M | $-28M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | 362200.0% | · | · | -31415.3% | · | |
| Net Margin | · | · | · | · | · | · | · | -362000.0% | · | · | -31154.0% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | 31154.0% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | 362200.0% | · | · | -30452.3% | · | |
| ROA | -30.0% | -159.4% | -120.2% | -100.1% | -52.6% | · | · | -84.6% | -105.5% | -495.9% | -135.8% | -88.5% | |
| ROE | -24.4% | -311.9% | -181.1% | -205.4% | -70.2% | · | · | -195.9% | -130.2% | -1184.2% | -13931.0% | -314.4% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 23.3 | 2.4 | 2.1 | 4.3 | 8.0 | · | · | 1.2 | 20.7 | 4.2 | 1.5 | 2.3 | |
| Quick Ratio | 23.0 | 2.2 | 1.7 | 4.0 | 7.8 | · | · | 1.1 | 20.4 | 3.5 | 1.2 | 2.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -22.2 | 28.9 | -72.5 | -23.9 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | · | · | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $0.18 | $0.38 | $0.92 | $2.02 | · | · | $0.44 | $0.33 | $0.11 | $-0.00 | $0.09 | |
| Cash Flow / Share | $-0.28 | $-0.56 | $-0.84 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.06 | $0.16 | $0.21 | $0.31 | $1.90 | · | · | $1.74 | $0.36 | $0.17 | $0.11 | $0.36 | |
| EPS (TTM) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $114.2K | $116.9K | $1M | |
| Net Income TTM | $-13M | $-11M | $-11M | $-13M | $-11M | $-9M | $-7M | $-7M | $-8M | $-10M | $-921.0K | $-33M | |
| Market Cap | $134M | $22M | $19M | $24M | $53M | · | · | $5M | $457M | $1.45B | $75.76B | $104.66B | |
| P/E | -6.9 | -1.5 | -1.6 | -1.7 | · | · | · | · | · | · | · | · | |
| P/S | 1175.8 | 190.2 | 168.1 | 207.9 | 466.7 | · | · | 45.4 | 4001.9 | 12693.8 | 648158.8 | 103420.7 | |
| P/B | 1.7 | 6.2 | 4.3 | 3.3 | 3.7 | · | · | 3.9 | 45.9 | 855.0 | -226687.8 | 17827.6 | |
| P / Tangible Book | 1.7 | 6.2 | 4.3 | 3.3 | 3.7 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -10.3 | -2.5 | -2.3 | -2.1 | -5.7 | · | · | -1.0 | -94.1 | -1844.9 | -2469.5 | -3826.4 | |
| P / FCF | -10.2 | -2.5 | -2.2 | -2.0 | -5.7 | · | · | -0.9 | -93.0 | -1788.0 | -2387.4 | -3704.0 | |
| Earnings Yield | -14.5% | -65.2% | -64.0% | -60.1% | · | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $241.0K | $105.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cost of Revenue | $884.0K | $103.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | $-643.0K | $2.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $2M | $1M | $2M | $1M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $4M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $1M | $938.0K | $932.0K | $959.0K | $1M | $1M | $2M | |
| Operating Income | $-6M | $-4M | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Other Non-op | · | · | · | · | · | $316.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-6M | $-4M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-2M | $-2M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $-0.08 | $-0.05 | $-0.04 | $-0.07 | $-0.10 | $-0.08 | $-0.19 | $-0.20 | $-0.17 | $-0.17 | $-0.23 | $-0.21 | $-0.25 | $-0.36 | $-0.38 | $-0.49 | |
| EPS (Diluted) | $-0.08 | $-0.05 | $-0.04 | $-0.07 | $-0.10 | $-0.08 | $-0.19 | $-0.20 | $-0.17 | $-0.17 | $-0.23 | $-0.21 | $-0.25 | $-0.36 | $-0.38 | $-0.49 | |
| Shares (Basic) | 67,163,613 | 67,158,044 | · | 48,095,384 | 36,488,014 | 31,085,606 | · | 16,471,419 | 14,846,584 | 14,055,973 | · | 11,707,317 | 9,198,806 | 8,013,295 | · | 7,108,133 | |
| Shares (Diluted) | 67,163,613 | 67,158,044 | · | 48,095,384 | 36,488,014 | 31,085,606 | · | 16,471,419 | 14,846,584 | 14,055,973 | · | 11,707,317 | 9,198,806 | 8,013,295 | · | 7,108,133 | |
| EBITDA | $-6M | $-4M | · | $-4M | $-4M | $-3M | · | $-3M | $-3M | $-2M | · | $-3M | $-2M | $-3M | · | $-3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $4M | $7M | $4M | $3M | $3M | $479.0K | $2M | $1M | $2M | $1M | $6M | $2M | $2M | $4M | |
| Short-term Investments | $64M | $69M | $75M | $73M | $29M | $27M | $2M | $4M | $4M | $5M | $4M | $7M | $4M | $3M | $6M | $2M | |
| Receivables | $176.0K | $105.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $3M | $2M | $584.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $709.0K | $660.0K | $644.0K | $573.0K | $164.0K | $218.0K | $300.0K | $609.0K | $628.0K | $603.0K | $152.0K | $208.0K | $371.0K | $475.0K | $532.0K | $193.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | $1M | · | · | · | · | · | |
| Current Assets | $72M | $77M | $80M | $81M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $8M | $10M | $6M | $9M | $7M | |
| PP&E (Net) | $316.0K | $188.0K | $93.0K | $78.0K | $75.0K | $78.0K | $80.0K | $99.0K | $122.0K | $132.0K | $146.0K | $184.0K | $180.0K | $196.0K | $221.0K | $258.0K | |
| PP&E (Gross) | · | · | $724.0K | · | · | · | $664.0K | · | · | · | $639.0K | · | · | · | $608.0K | · | |
| Accum. Depreciation | · | · | $631.0K | · | · | · | $584.0K | · | · | · | $493.0K | · | · | · | $387.0K | · | |
| Total Assets | $73M | $78M | $82M | $82M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $9M | $11M | $6M | $10M | $7M | |
| Accounts Payable | $871.0K | $1M | $511.0K | $509.0K | $503.0K | $186.0K | $165.0K | $246.0K | $178.0K | $96.0K | · | $238.0K | $240.0K | $224.0K | · | $287.0K | |
| Accrued Liabilities | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $896.0K | $1M | $1M | $859.0K | $743.0K | $2M | $1M | |
| Current Liabilities | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $1M | $4M | $1M | $1M | $1M | $2M | $2M | |
| Capital Leases | $550.0K | $574.0K | $569.0K | $602.0K | $47.0K | $48.0K | $41.0K | $29.0K | $38.0K | $17.0K | $40.0K | $39.0K | $92.0K | $127.0K | $179.0K | $226.0K | |
| Total Liabilities | $4M | $4M | $4M | $4M | $3M | $2M | $3M | $1M | $1M | $1M | $4M | $2M | $1M | $1M | $2M | $2M | |
| Common Stock | $672.0K | $672.0K | $672.0K | $659.0K | $380.0K | $348.0K | $195.0K | $168.0K | $161.0K | $145.0K | $118.0K | $118.0K | $118.0K | $83.0K | $80.0K | $72.0K | |
| Retained Earnings | $-113M | $-108M | $-104M | $-101M | $-97M | $-94M | $-91M | $-88M | $-84M | $-82M | $-80M | $-76M | $-74M | $-72M | $-69M | $-66M | |
| Stockholders' Equity | $69M | $74M | $78M | $78M | $30M | $29M | $4M | $4M | $6M | $6M | $5M | $7M | $9M | $5M | $7M | $6M | |
| Liabilities + Equity | $73M | $78M | $82M | $82M | $33M | $31M | $6M | $5M | $7M | $7M | $8M | $9M | $11M | $6M | $10M | $7M | |
| Shares Outstanding | 67,164,801 | 67,158,044 | 67,158,044 | 65,833,556 | 37,958,316 | 34,744,476 | 19,399,513 | 16,651,433 | 15,965,633 | 14,398,964 | 11,707,317 | 11,707,317 | 11,707,317 | 8,130,628 | 7,890,628 | 7,108,133 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15.0K | $12.0K | $10.0K | $10.0K | $12.0K | $15.0K | $26.0K | $23.0K | $14.0K | $28.0K | $35.0K | $20.0K | $26.0K | $25.0K | $33.0K | $25.0K | |
| Stock-based Comp | $433.0K | $222.0K | $236.0K | $328.0K | $237.0K | $256.0K | $282.0K | $283.0K | $331.0K | $453.0K | $297.0K | $336.0K | $349.0K | $412.0K | $430.0K | $461.0K | |
| Other Non-cash | · | $-2M | · | · | · | $-544.0K | · | · | · | $-530.0K | · | · | · | $-787.0K | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-4M | $-4M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | |
| CapEx | $142.0K | $108.0K | $25.0K | $13.0K | $9.0K | $13.0K | $7.0K | $0 | $4.0K | $14.0K | $-5.0K | $28.0K | · | · | $1.0K | $5.0K | |
| Investing Cash Flow | $4M | $5M | $-2M | $-45M | $-1M | $-25M | $1M | $140.0K | $1M | $-1M | $3M | $-3M | $-1M | $3M | $-4M | $-5.0K | |
| Financing Cash Flow | · | · | $3M | $51M | $5M | $28M | $3M | $633.0K | $2M | $2M | $0 | $-161.0K | · | · | · | · | |
| Net Change in Cash | $-502.0K | $-56.0K | $-3M | $3M | $870.0K | $102.0K | $3M | $-2M | $1M | $-1M | $1M | $-4M | $4M | $-320.0K | $-2M | $-3M | |
| Free Cash Flow | · | $-5M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -266.8% | 1.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -2567.6% | -4114.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -2334.9% | -3496.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -2567.6% | -4102.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -10.6% | -6.7% | · | -8.2% | -17.3% | -13.6% | · | -45.6% | -26.9% | -34.9% | · | -30.0% | -21.3% | -28.7% | · | -25.6% | |
| ROE | -11.3% | -7.1% | · | -8.7% | -19.2% | -14.8% | · | -57.6% | -31.8% | -43.0% | · | -38.0% | -25.4% | -34.6% | · | -29.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.6 | 22.6 | · | 27.5 | 12.1 | 16.2 | · | 3.6 | 5.3 | 5.9 | · | 5.6 | 7.8 | 4.5 | · | 4.0 | |
| Quick Ratio | 17.4 | 21.4 | · | 27.3 | 12.0 | 16.1 | · | 3.2 | 4.8 | 5.4 | · | 5.5 | 7.5 | 4.1 | · | 3.8 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory Turnover | 0.6 | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.7 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.03 | $1.10 | · | $1.19 | $0.80 | $0.83 | · | $0.23 | $0.38 | $0.43 | · | $0.63 | $0.81 | $0.60 | · | $0.78 | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.09 | · | · | · | $-0.17 | · | · | · | · | · | · | |
| Cash / Share | $0.05 | $0.05 | · | $0.10 | $0.11 | $0.09 | · | $0.03 | $0.15 | $0.08 | · | $0.11 | $0.49 | $0.26 | · | $0.61 | |
| EPS (TTM) | $-0.24 | $-0.26 | · | $-0.44 | $-0.57 | $-0.64 | · | $-0.77 | $-0.78 | $-0.86 | · | $-1.20 | $-1.48 | $-1.72 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $114.2K | $114.2K | $114.2K | · | $114.2K | $114.2K | $114.2K | · | $114.2K | $114.2K | $114.2K | · | $114.2K | |
| Net Income TTM | $-16M | $-14M | · | $-13M | $-13M | $-12M | · | $-11M | $-10M | $-10M | · | $-11M | $-12M | $-13M | · | $-14M | |
| Market Cap | $131M | $162M | · | $201M | $96M | $52M | · | $15M | $16M | $18M | · | $16M | $32M | $17M | · | $34M | |
| P/E | -8.1 | -9.3 | · | -6.9 | -4.4 | -2.4 | · | -1.2 | -1.3 | -1.4 | · | -1.2 | -1.8 | -1.2 | · | · | |
| P/S | · | · | · | 1757.7 | 837.3 | 459.3 | · | 129.7 | 142.6 | 155.0 | · | 142.5 | 278.8 | 148.0 | · | 297.4 | |
| P/B | 1.9 | 2.2 | · | 2.6 | 3.2 | 1.8 | · | 3.9 | 2.7 | 2.9 | · | 2.2 | 3.4 | 3.5 | · | 6.1 | |
| P / Tangible Book | 1.9 | 2.2 | · | 2.6 | 3.2 | 1.8 | · | 3.9 | 2.7 | 2.9 | · | 2.2 | 3.4 | 3.5 | · | 6.1 | |
| P / Cash Flow | · | -32.0 | · | · | · | -18.3 | · | · | · | -7.3 | · | · | · | -5.3 | · | · | |
| Earnings Yield | -12.3% | -10.8% | · | -14.4% | -22.6% | -42.4% | · | -86.5% | -76.5% | -69.9% | · | -86.3% | -54.4% | -82.7% | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-13M | $-11M | $-11M | $-13M | $-11M |
| Diluted EPS | $-0.29 | $-0.73 | $-1.05 | $-1.81 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 23.3 | 2.4 | 2.1 | 4.3 | 8.0 |
| Quick Ratio | 23.0 | 2.2 | 1.7 | 4.0 | 7.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-13M | $-9M | $-9M | $-12M | $-9M |
Institutional owners (13F) 83 filers · $34.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
83
Value held
$34.4M
New positions
11
Exited positions
17
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (-13 vs prior Q) | 17 (+6 vs prior Q) | 24 (-3 vs prior Q) | 16 (+1 vs prior Q) | -2.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6,659,442 | 3,329,721 | 19.36% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $5,668,280 | 2,906,810 | 16.48% | Shares |
| CIBC Private Wealth Group LLC | $4,434,700 | 1,454,000 | 12.90% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $2,473,483 | 1,268,453 | 7.19% | Shares |
| BlackRock, Inc. | $1,759,701 | 902,411 | 5.12% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,631,472 | 836,271 | 4.74% | Shares |
| UBS Group AG | $1,573,352 | 806,847 | 4.58% | Shares |
| DNB Asset Management AS | $1,321,121 | 677,498 | 3.84% | Shares |
| STIFEL FINANCIAL CORP | $1,150,367 | 589,924 | 3.35% | Shares |
| MARSHALL WACE, LLP | $1,056,831 | 541,963 | 3.07% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,025,363 | 525,827 | 2.98% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $840,514 | 431,033 | 2.44% | Shares |
| STATE STREET CORP | $591,960 | 303,569 | 1.72% | Shares |
| AlphaCentric Advisors LLC | $487,500 | 250,000 | 1.42% | Shares |
| WOLVERINE TRADING, LLC | $335,680 | 104,900 | 0.98% | Call option |
| NORTHERN TRUST CORP | $287,684 | 147,530 | 0.84% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $245,115 | 125,700 | 0.71% | Put option |
| GROUP ONE TRADING LLC | $207,537 | 106,429 | 0.60% | Shares |
| JANE STREET GROUP, LLC | $206,961 | 106,134 | 0.60% | Shares |
| AMERICAN CENTURY COMPANIES INC | $181,962 | 93,314 | 0.53% | Shares |
| CITADEL ADVISORS LLC | $180,375 | 92,500 | 0.52% | Call option |
| MILLENNIUM MANAGEMENT LLC | $168,289 | 86,302 | 0.49% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $166,335 | 85,300 | 0.48% | Call option |
| Cubist Systematic Strategies, LLC | $118,904 | 38,985 | 0.35% | Shares |
| Invesco Ltd. | $101,792 | 52,201 | 0.30% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $97,500 | 50,000 | 0.28% | Shares |
| Vontobel Holding Ltd. | $93,772 | 48,088 | 0.27% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $92,481 | 47,426 | 0.27% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $86,385 | 44,300 | 0.25% | Shares |
| Cetera Investment Advisers | $85,433 | 43,812 | 0.25% | Shares |
| WOLVERINE TRADING, LLC | $75,520 | 23,600 | 0.22% | Put option |
| LAZARI CAPITAL MANAGEMENT, INC. | $71,370 | 36,600 | 0.21% | Shares |
| Hilltop Holdings Inc. | $69,740 | 35,764 | 0.20% | Shares |
| XTX Topco Ltd | $67,101 | 34,411 | 0.20% | Shares |
| SCOTIA CAPITAL INC. | $64,108 | 32,876 | 0.19% | Shares |
| Beacon Capital Management, LLC | $62,400 | 32,000 | 0.18% | Shares |
| CITADEL ADVISORS LLC | $62,400 | 32,000 | 0.18% | Put option |
| SIMPLEX TRADING, LLC | $58,868 | 30,189 | 0.17% | Shares |
| LPL Financial LLC | $57,798 | 29,640 | 0.17% | Shares |
| Private Advisor Group, LLC | $44,560 | 22,851 | 0.13% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $42,107 | 22,279 | 0.12% | Shares |
| Squarepoint Ops LLC | $39,558 | 20,286 | 0.12% | Shares |
| Vanguard Global Advisers, LLC | $38,943 | 19,971 | 0.11% | Shares |
| OSAIC HOLDINGS, INC. | $32,375 | 16,605 | 0.09% | Shares |
| Caitong International Asset Management Co., Ltd | $26,411 | 13,544 | 0.08% | Shares |
| Qube Research & Technologies Ltd | $26,313 | 13,494 | 0.08% | Shares |
| Focus Partners Wealth | $25,321 | 12,985 | 0.07% | Shares |
| MORGAN STANLEY | $23,504 | 12,053 | 0.07% | Shares |
| Tower Research Capital LLC (TRC) | $22,324 | 11,448 | 0.06% | Shares |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $21,450 | 11,000 | 0.06% | Shares |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Harel Gadot, MEDX Ventures Group LLC ×4 filings | Jan. 2, 2020 | · | Initial filing | · | SEC |
| Yoseph Bornstein, LSA- Life Science Accelerator Ltd. ×4 filings | Oct. 26, 2017 | · | Initial filing | · | SEC |
| Moshe Shoham ×4 filings | Oct. 18, 2017 | · | Initial filing | · | SEC |
| Avram Berkson, Sandra Berkson, Saber Holding GmbH ×3 filings | June 20, 2017 | · | Initial filing | Passive investment | SEC |
| Technion Research and Development Foundation Ltd. ×2 filings | Jan. 9, 2017 | · | Initial filing | Passive investment | SEC |
| Alpha Capital Anstalt (2) | Dec. 8, 2016 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 36 insiders · 16 officers · 20 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Harel Gadot | Chairman, President and CEO | Feb. 18, 2026 A | 136,847 | 0 | 0 | $0 |
| Ian J Massey | Chief Executive Officer | March 15, 2016 A | 2,378,460 | 0 | 0 | $0 |
| Martin M Mcglynn | President & CEO | Jan. 8, 2016 F | 2,230,297 | 0 | 0 | $0 |
| Rachel Vaknin | Chief Financial Officer | Feb. 18, 2026 A | · | 0 | 0 | $0 |
| David Ben Naim | Chief Financial Officer | Dec. 28, 2017 A | · | 0 | 0 | $0 |
| Gregory T Schiffman | Chief Financial Officer | March 14, 2016 P | 1,599,717 | 0 | 0 | $0 |
| Rodney Kb Young | CFO | June 1, 2013 F | 36,745 | 0 | 0 | $0 |
| Judi R Lum | CFO | Sept. 30, 2005 J | 1,421 | 0 | 0 | $0 |
| Yehezkel Himelfarb | COO and General Manager | Oct. 15, 2017 A | · | 0 | 0 | $0 |
| Juan Diaz-Cartelle | Chief Medical Officer | Feb. 18, 2026 A | · | 0 | 0 | $0 |
| Simon Sharon | General Manager, CTO | Feb. 18, 2026 A | · | 0 | 0 | $0 |
| Eyal Morag | Chief Medical Officer | Aug. 1, 2023 A | · | 0 | 0 | $0 |
| Kenneth Blair Stratton | General Counsel | June 17, 2016 F | 42,273 | 0 | 0 | $0 |
| Ann Tsukamoto | EVP, Research and Development | Jan. 27, 2015 F | 706,511 | 0 | 0 | $0 |
| Stewart Craig | SVP, Development & Operations | Jan. 27, 2014 F | 405,981 | 0 | 0 | $0 |
| Eliseo Oreste Salinas | EVP and Head of R&D | June 6, 2013 A | 390,000 | 0 | 0 | $0 |
| David James Wilson | Director | April 1, 2026 A | · | 0 | 0 | $0 |
| Tal Baruch Wenderow | Director | April 1, 2026 A | · | 0 | 0 | $0 |
| Aileen Ptucha Stockburger | Director | April 1, 2026 A | · | 0 | 0 | $0 |
| Prattipati Laxminarain | Director | April 1, 2026 A | · | 0 | 0 | $0 |
| Martin J. Madden | Director | April 1, 2026 A | · | 0 | 0 | $0 |
| Scott R Burell | Director | April 1, 2026 A | · | 0 | 0 | $0 |
| Yoseph Bornstein | Director | Nov. 2, 2023 A | 246,909 | 0 | 0 | $0 |
| Yoav Zvi Waizer | Director | Oct. 23, 2019 A | 0 | 0 | 0 | $0 |
| Moshe Shoham | Director | Oct. 9, 2017 S | 1,558,390 | 0 | 0 | $0 |
| Irving Weissman | Director | April 1, 2016 A | 558,288 | 0 | 0 | $0 |
| Alan O Trounson | Director | Jan. 1, 2016 A | 354,595 | 0 | 0 | $0 |
| John J Schwartz | Director | Jan. 1, 2016 A | 334,673 | 0 | 0 | $0 |
| Scott R Greer | Director | Jan. 1, 2016 A | 290,183 | 0 | 0 | $0 |
| Eric Bjerkholt | Director | Jan. 1, 2016 A | 273,759 | 0 | 0 | $0 |
| Ricardo B Levy | Director | Jan. 1, 2016 A | 260,033 | 0 | 0 | $0 |
| Roger M Perlmutter | Director | Dec. 14, 2012 A | 13,000 | 0 | 0 | $0 |
| Desmond H Oconnell JR | Director | March 7, 2007 P | 10,500 | 0 | 0 | $0 |
| Leon Lewkowicz | 10% owner | June 16, 2017 S | 3,078,214 | 0 | 0 | $0 |
| Alpha Capital Anstalt | 10% owner | Nov. 28, 2016 J | 1,776,457 | 0 | 0 | $0 |
| George Koshy | · | May 24, 2016 F | 27,308 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
MBOT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$4.00
+244.8%
2 22.2%
Strong Buy
6 66.7%
Buy
1 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-03Mean target $6.33 +446.0%
← Below all targets
Current price $1.16
Low$3.00
Mean$6.33
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026